Back to search
Lateral Sclerosis Amyotrophy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lateral Sclerosis Amyotrophy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Lateral Sclerosis Amyotrophy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Amyotrophic Lateral Sclerosis (ALS) is a nervous system disease that causes muscle weakness and rapidly progresses to the loss of mobility and functionality. St…
The goal of this clinical trial is to learn if the drug pridopidine works to treat amyotrophic lateral sclerosis in adults. It will also help to learn about the…
Amyotrophic lateral sclerosis (ALS) is a disease that causes weakness of the muscles of the body. The disease can eventually lead to severe breathing problems,…
This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3…
The goal of this clinical trial is to evaluate whether tofersen is safe and effective in adults with non-SOD1 ALS. Tofersen is currently approved by the U.S. Fo…
Study OLMP is a master protocol that will support a collection of individual sub studies that share key design components. Participants from the originator stud…
This is a single-session, case-control study that incorporates digital tools for assessing speech and motor function in motor neuron disease. Patients with moto…
The FUNCtion Amyotrophic Lateral Sclerosis (ALS) trial is a randomized, double-blind, placebo-controlled Phase 1/2 trial to evaluate the safety and tolerability…